v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 222,786 $ 190,680
Accounts receivable, net 74,157 54,093
Inventory 28,506 23,802
Prepaid expenses and other current assets 7,606 4,826
Total current assets 333,055 273,401
Property, plant and equipment, net 20,838 11,844
Operating lease right-of-use assets, net 4,358 3,949
Indemnification asset, related party 8,547 8,392
Contract acquisition costs, net 6,669 6,818
Intangible asset, net 2,887 2,952
Goodwill 3,903 3,903
Deferred tax assets, net 873  
Restricted cash 3,504 3,504
Other assets 16,899 13,171
Total assets 401,533 327,934
Current liabilities:    
Accounts payable 10,981 3,678
Accrued expenses and other current liabilities 87,729 73,197
Long-term debt, current 50,223 58,406
Operating and finance lease liabilities, current 807 487
Total current liabilities 149,740 135,768
Litigation finance payable 8,547 8,384
Long-term debt, noncurrent 127,643 132,935
Operating and finance lease liabilities, noncurrent 6,151 6,099
Long-term tax liability 873  
Total liabilities 292,954 283,186
Commitments and contingencies (Note 13)
Stockholders' equity:    
Preferred stock - 10,000,000 shares authorized, none outstanding 0 0
Common stock - $0.001 par value, 115,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively, 88,308,411 and 87,204,137 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 88 87
Additional paid-in capital 681,942 670,974
Accumulated deficit (573,451) (626,313)
Total stockholders' equity 108,579 44,748
Total liabilities and stockholders' equity $ 401,533 $ 327,934